Table 2 Univariate analysis predictive factors of Long COVID
From: Symptoms and risk factors for long COVID in Tunisian population
Factor | Long COVID n(%) | p value | OR CI95% | |
|---|---|---|---|---|
Yes | No | |||
Gender | Â | Â | Â | Â |
Male | 95(6.9) | 185 (13.4) | Reference | Reference |
Female | 547(39.6) | 554(40.1) | ≤10 -3 | 1.92 (1.46-2.52) |
BMI | Â | Â | Â | Â |
<18,5 | 17(1.2) | 22(1.6) | 0.964 | 0.95 (0.52-1.89) |
18,5-25 | 251(18.2) | 320(23.2) | Reference | Reference |
25-30 | 237(17.2) | 270(19.5) | 0.359 | 1.11 (0.88 -1.42) |
>30 | 137(9.9) | 127(9.2) | 0.033 | 1.02 (1.06 -1.84) |
Smoking status | Â | Â | Â | Â |
No | 546(39.5) | 593(42.9) | Reference | Reference |
Yes | 96(7) | 146(10.6) | 0.02 | 0.71 (0.53-0.94) |
Number of symptoms in acute COVID | Â | Â | Â | Â |
0 | 7(0.5) | 15(1.1) | Reference | Reference |
1-5 | 134(9.7) | 255(18.4) | 0.43 | 1.40 (0.60-3.24) |
>5 | 501(36.3) | 469(34) | 0.008 | 3.05 (1.33-6.98) |
Severity of acute COVID | Â | Â | Â | Â |
No Hospitalization | 590(42.7) | 705(51) | Reference | Reference |
Hospitalized in a medical unit | 40(2.9) | 32(2.4) | 0.1 | 1.49 (0.92-2.40) |
Hospitalized in intensive care unit | 12(0.9) | 2(0.1) | 0.01 | 7.16 (1.59-32.16) |
Symptoms in acute COVID | Â | Â | Â | Â |
Soreness | 427(30.9) | 437(31.6) | 0.007 | 1.35 (1.08-1.68) |
Chest pain | 215(15.6) | 252(18.2) | ≤10 -3 | 1.57 (1.25-1.97) |
Anosmia | 496(35.9) | 439(31.8) | ≤10 -3 | 2.32 (1.83-2.93) |
Ageusia | 450(32.6) | 390(28.2) | ≤10 -3 | 2.09 (1.67-2.61) |
Nausea | 199(14.4) | 147(10.6) | ≤10 -3 | 1.80 (1.41-2.31) |
Vomit | 131(9.5) | 91(6.6) | ≤10 -3 | 1.82 (1.36-2.44) |
Diarrhea | 226(16.4) | 276(20) | ≤10 -3 | 1.71 (1.37-2.13) |
Arthralgia | 413(29.9) | 402(29.1) | ≤10 -3 | 1.51 (1.21-1.87) |
Myalgia | 301(21.8) | 284(20.6) | 0.002 | 1.41 (1.14-1.75) |
Dyspnea | 184(13.3) | 115(8.3) | ≤10 -3 | 2.18 (1.67-2.83) |
Fatigue | 510(36.9) | 550(39.8) | 0.028 | 1.32 (1.03-1.71) |
Rhinorrhea | 229(16.6) | 312(22.6) | 0.013 | 0.75 (0.61-0.94) |
Rash | 48(3.5) | 23(1.7) | ≤10 -3 | 2.51 (1.51-4.18) |
Comorbidities | Â | Â | Â | Â |
No | 472(34.2) | 984(71.2) | Reference | Reference |
Yes | 170(12.3) | 253(18.3) | Â 0.002 | 1.48 (1.15-1.91) |
Comorbidity | Â | Â | Â | Â |
Respiratory affection | 50(3.6) | 38(2.7) | 0.046 | 1.55(1.00-2.40) |
Vaccination status | Â | Â | Â | Â |
No | 507(36.7) | 505(36.6) | Reference | Reference |
Partially | 50(3.6) | 56(4) | 0.56 | 0.88 (0.59-1.32) |
Complete | 85(6.1) | 179(13) | ≤10 -3 | 0.47 (0.35-0.62) |